Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas
NCT ID: NCT05788029
Last Updated: 2025-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
212 participants
INTERVENTIONAL
2024-01-01
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer
NCT03792932
Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma
NCT06344299
Investigation of Pancreaticoduodenectomy
NCT03791450
Standardization of Surgery on the Pancreatic Cancer
NCT00679913
Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms
NCT02125929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
laparoscopic pancreaticoduodenectomy
laparoscopic pancreaticoduodenectomy
laparoscopic pancreaticoduodenectomy
laparoscopic pancreaticoduodenectomy
open pancreaticoduodenectomy
open pancreaticoduodenectomy
open pancreaticoduodenectomy
open pancreaticoduodenectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laparoscopic pancreaticoduodenectomy
laparoscopic pancreaticoduodenectomy
open pancreaticoduodenectomy
open pancreaticoduodenectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Histologically confirmed NPPC or clinically diagnosed NPPC by an MDT without histopathologic evidence.
3. Patients feasible to undergo both LPD and OPD ac- cording to MDT evaluations.
4. Patients understanding and willing to comply with this trial.
5. Provision of written informed consent before patient registration.
6. Patients meeting the curative treatment intent in ac- cordance with clinical guidelines.
Exclusion Criteria
2. Patients requiring left, central or total pancreatecto- my or other palliative surgery.
3. Preoperative American Society of Anaesthesiologists (ASA) score ≥4.
4. History of other malignant disease
5. Pregnant or breastfeeding women.
6. Patients with serious mental disorders
7. Patients treated with neoadjuvant therapy.
8. Patients with vascular invasion and requiring vascular resection as evaluated by the MDT team according to abdominal imaging data.
9. Body mass index \>35 kg/m 2 .
10. Patients participating in any other clinical trials with- in 3 months.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fudan University
OTHER
The First Affiliated Hospital of Dalian Medical University
OTHER
The Affiliated Hospital of Xuzhou Medical University
OTHER
The Third Affiliated Hospital of Soochow University
OTHER
Shanxi Province Cancer Hospital
OTHER
Army Medical University, China
OTHER
Qilu Hospital of Shandong University
OTHER
Nanfang Hospital, Southern Medical University
OTHER
The First Affiliated Hospital of University of South China
OTHER
First Affiliated Hospital of Harbin Medical University
OTHER
Chongqing General Hospital
OTHER
Tianjin Medical University Cancer Institute and Hospital
OTHER
Tongji Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Renyi Qin
Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Renyi Qin
Role: PRINCIPAL_INVESTIGATOR
Tongji Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Biliary and Pancreatic Surgery, Tongji Hospital, Affiliated Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TJDBPS14
Identifier Type: OTHER
Identifier Source: secondary_id
TJDBPS14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.